Reconsidering white matter vulnerability and biomarker interpretation across Lewy body dementia subtypes.
作者信息
Liu Shuo, Yang Siwen, Sui Yi
机构信息
Department of Neurology, The Fourth People's Hospital of Shenyang, Shenyang, China.
Department of Science, Yokohama City University, Yokohama, Japan.
出版信息
Alzheimers Dement. 2025 Aug;21(8):e70566. doi: 10.1002/alz.70566.
Abstract
摘要
相似文献
1
Reconsidering white matter vulnerability and biomarker interpretation across Lewy body dementia subtypes.重新审视路易体痴呆各亚型中的白质易损性及生物标志物解读
Alzheimers Dement. 2025 Aug;21(8):e70566. doi: 10.1002/alz.70566.
2
Reply: Reconsidering white matter vulnerability and biomarker interpretation across Lewy body dementia subtypes.回复：重新审视路易体痴呆各亚型中的白质易损性及生物标志物解读
Alzheimers Dement. 2025 Aug;21(8):e70567. doi: 10.1002/alz.70567.
3
Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes.路易体痴呆亚型的神经影像学和血浆生物标志物差异与共性
Alzheimers Dement. 2025 May;21(5):e70274. doi: 10.1002/alz.70274.
4
Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum.沿路易体连续体的脑血管共同病理学和胆碱能白质通路。
Brain Commun. 2025 May 6;7(3):fcaf173. doi: 10.1093/braincomms/fcaf173. eCollection 2025.
5
A systematic review of diffusion tensor imaging and tractography in dementia with Lewy bodies and Parkinson's disease dementia.路易体痴呆和帕金森病痴呆中弥散张量成像和纤维束成像的系统评价
Neurosci Biobehav Rev. 2025 Feb;169:106007. doi: 10.1016/j.neubiorev.2025.106007. Epub 2025 Jan 9.
6
Hippocampus and basal forebrain degeneration differentially impact cognition in Lewy body spectrum disorders.海马体和基底前脑变性对路易体谱系障碍的认知产生不同影响。
Brain. 2025 Aug 1;148(8):2772-2784. doi: 10.1093/brain/awaf070.
7
Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies.跨 Tau 病的新皮质灰质和白质 Tau 负荷的数字组织学研究。
J Neuropathol Exp Neurol. 2022 Nov 16;81(12):953-964. doi: 10.1093/jnen/nlac094.
8
Cerebrovascular and Alzheimer's disease biomarkers in dementia with Lewy bodies and other dementias.路易体痴呆和其他痴呆中的脑血管及阿尔茨海默病生物标志物
Brain Commun. 2024 Aug 28;6(5):fcae290. doi: 10.1093/braincomms/fcae290. eCollection 2024.
9
It is time to share Alzheimer biomarker results in dementia with Lewy bodies.是时候分享路易体痴呆症的阿尔茨海默病生物标志物结果了。
Alzheimers Dement (Amst). 2025 Jul 9;17(3):e70144. doi: 10.1002/dad2.70144. eCollection 2025 Jul-Sep.
10
White matter hyperintensities in cognitive impairment with Lewy body disease: a multicentre study.路易体病性认知障碍的脑白质高信号：一项多中心研究。
Eur J Neurol. 2023 Dec;30(12):3711-3721. doi: 10.1111/ene.16002. Epub 2023 Aug 7.
本文引用的文献
1
Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes.路易体痴呆亚型的神经影像学和血浆生物标志物差异与共性
Alzheimers Dement. 2025 May;21(5):e70274. doi: 10.1002/alz.70274.
2
Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies.路易体痴呆症中β-淀粉样蛋白、tau 和脑血管生物标志物与神经退行性变的横断面关联。
Neurology. 2023 Feb 21;100(8):e846-e859. doi: 10.1212/WNL.0000000000201579. Epub 2022 Nov 28.
3
Neuroinflammation and protein pathology in Parkinson's disease dementia.帕金森病痴呆的神经炎症和蛋白病理。
Acta Neuropathol Commun. 2020 Dec 3;8(1):211. doi: 10.1186/s40478-020-01083-5.
4
White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's disease.帕金森病中的白质高信号、脑脊液淀粉样β蛋白与痴呆
J Neurol Sci. 2016 Aug 15;367:284-90. doi: 10.1016/j.jns.2016.06.009. Epub 2016 Jun 11.
Zotero 插件